SCI & TECH● LOWSep 9 · Sep 9, 2026, 6:00 AM
As China embraces AI, only 24% of US pharma execs bet on it for drug-making
South China Morning Post · global
Pharmaceutical companies have embraced artificial intelligence in drug research almost universally, yet few company executives expect AI to actually make drugs succeed, according to a Citi survey released on Tuesday. “The biggest risk to the AI-powered drug discovery thesis is not that AI fails to accelerate discovery,” said John Yung, head of Asia healthcare research at the US investment bank. “The stronger risk is that acceleration does not translate into better drugs or higher probability of...
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH2h agoSouth Korea’s latest chart sensation has a secret: the singer isn’t humanSouth China Morning PostSCI & TECH4h agoZohran Mamdani invested 29.2 million dollars in New York University's quantum laboratoryClarínSCI & TECH4h agoScientists first noticed Alaska's rivers turning orange in 2018; new research reveals that waters in pristine areas can be more acidic and metal-rich than wastewater from metal minesClarínSCI & TECH7h agoEduardo Díaz de Guijarro: "In times of Artificial Intelligence, the distinguishing feature of Universities is to return to thinking, criticism, the human"Clarín